Heath P T, Booy R, Azzopardi H J, Slack M P, Fogarty J, Moloney A C, Ramsay M E, Moxon E R
Oxford Vaccine Group, UK.
Pediatr Infect Dis J. 2001 Mar;20(3):300-5. doi: 10.1097/00006454-200103000-00016.
As a result of the decline in Haemophilus influenzae type b (Hib) disease caused by the widespread use of conjugate vaccines, non-type b H. influenzae will become a more important cause of H. influenzae (Hi) disease. Characterization of the clinical and epidemiologic features of non-b Hi disease is needed in the Hib vaccine era.
A prospective active surveillance study of invasive Hi disease involving pediatricians in the United Kingdom and Republic of Ireland. For the first phase of the study (October 1, 1992, to October 31, 1995) pediatricians were asked to report any child who had invasive Hi disease and who had received Hib conjugate vaccine. For the second phase of the study (November 1, 1995. To December 31, 1998) pediatricians were asked to report any child with invasive Hi disease regardless of vaccination status.
During the study period 102 cases of invasive non-type b Hi disease and 106 cases of invasive Hib disease were reported in children who had been fully vaccinated against Hib. Children with non-type b disease were younger (16 vs. 22 months of age, P = 0.08), less likely to have meningitis and epiglottitis (P < or = 0.001) and more likely to have pneumonia and bacteremia (P < or = 0.001) than children with type b disease. For the last 2 years of the study invasive Hi disease occurring in a fully vaccinated child was more likely to be caused by a non-b strain than by a type b strain (58 vs. 38). In 1998 the incidence of non type-b Hi disease in all children <5 years of age in the UK was 1.3/100,000 as compared with an incidence of Hib disease of 0.6/100,000. The majority (88%) of non-b strains isolated in children were nontypable strains.
Non-b Hi is a rare cause of disease in children, but in the Hib vaccine era it has become more common than type b as a cause of Hi disease in fully vaccinated children.
由于广泛使用结合疫苗导致b型流感嗜血杆菌(Hib)疾病发病率下降,非b型流感嗜血杆菌将成为流感嗜血杆菌(Hi)疾病更重要的病因。在Hib疫苗时代,需要对非b型Hi疾病的临床和流行病学特征进行描述。
在英国和爱尔兰共和国,对儿科医生进行的侵袭性Hi疾病前瞻性主动监测研究。在研究的第一阶段(1992年10月1日至1995年10月31日),要求儿科医生报告任何患有侵袭性Hi疾病且接种过Hib结合疫苗的儿童。在研究的第二阶段(1995年11月1日至1998年12月31日),要求儿科医生报告任何患有侵袭性Hi疾病的儿童,无论其疫苗接种状况如何。
在研究期间,报告了102例侵袭性非b型Hi疾病病例和106例侵袭性Hib疾病病例,这些儿童均已完全接种Hib疫苗。与b型疾病儿童相比,非b型疾病儿童年龄更小(分别为16个月和22个月,P = 0.08),患脑膜炎和会厌炎的可能性更小(P≤0.001),患肺炎和菌血症的可能性更大(P≤0.001)。在研究的最后两年,完全接种疫苗的儿童中发生的侵袭性Hi疾病更可能由非b型菌株而非b型菌株引起(分别为58例和38例)。1998年,英国所有5岁以下儿童中非b型Hi疾病的发病率为1.3/100,000,而Hib疾病的发病率为0.6/100,000。在儿童中分离出的大多数(88%)非b型菌株为不可分型菌株。
非b型Hi是儿童疾病的罕见病因,但在Hib疫苗时代,它已成为完全接种疫苗儿童中Hi疾病的病因,比b型更为常见。